Toxicities included grade 3 vomiting (one patient) grade 3 diarrhea (four patients), grade ... interrupt or reduce the dose of erlotinib and/or FOLFIRI in all six patients, and no patient received ...

The recommended dose for oral continuous scheduling is 150 mg/day. Major toxicities induced by erlotinib treatment are diarrhea and acne-like skin rash. No survival advantage has been seen with ...

The patient developed a well-disseminated rash and diarrhea soon after starting erlotinib. He described the diarrhea as "frequent" and "horrible" and started taking loperamide according to the ...

Although EGFR amplification does not correlate with improved survival, these results suggest that erlotinib prolongs time to progression in patients with NSCLC whose tumors show increased copy ...

As such, probiotic supplements and probiotic-rich foods have become popular natural treatments for a number of health conditions, including digestive issues like diarrhea. Diarrhea has a number of ...

Diarrhea is one of the most common antibiotic side effects. About 1 in 5 people who take antibiotics have loose stools, according to Mayo Clinic. Antibiotics are medicines that kill bacteria ...

When you have diarrhea, you pass loose or watery stool more than three times a day. It's a common problem and in most cases isn't indicative of any underlying conditions. However, it can be ...

Diarrhea is a symptom of many health conditions. It refers to passing runny or loose stool more than three times a day. You might experience diarrhea along with cramping, intense urges to poop ...

I think it's part of life for people to occasionally get episodes of diarrhea. For acute diarrhea, we look at acute infections. We may not do anything except to treat it symptomatically or do a ...

Eating bland, easy-to-digest foods and drinking electrolytes can relieve diarrhea. Foods like crackers, chicken broth and ...

The drug joins the competition in the targeted-therapy market in lung cancer, where Roche's Tarceva (erlotinib) and AstraZeneca's Iressa (gefitinib) are already well established. NICE says Giotrif ...

These results aligned with earlier trials of first-generation EGFR TKIs such as the phase III NEJ026 and ARTEMIS trials, which showed that combination therapy with erlotinib (Tarceva) and ...